New China Contract Research Organization Industry(CRO)

  • 340 views
Uploaded on

Compared to Europe and America, China developed pharmaceutical CRO industry 40 years later, with domestic industrial players amounting to over 500, most of which are SMEs. In general, Chinese CRO …

Compared to Europe and America, China developed pharmaceutical CRO industry 40 years later, with domestic industrial players amounting to over 500, most of which are SMEs. In general, Chinese CRO market scale occupies only 7%-10% of the world’s total, and in 2011-2012 the CRO market size of China approximated RMB22-28 billion.

More in: Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
340
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
1
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. China Contract Research Organization (CRO) Industry Report, 2012-2013Description Compared to Europe and America, China developed pharmaceutical CRO industry 40 years later, withdomestic industrial players amounting to over 500, most of which are SMEs. In general, Chinese CRO marketscale occupies only 7%-10% of the world’s total, and in 2011-2012 the CRO market size of Chinaapproximated RMB22-28 billion. Considering huge potentials of Chinese phramceutical market, intensive talent resource, relatively low costand rich spectrum of diseases, foreign enterprises are accelerating to expand CRO market there. Presently,world-renowned CRO companies including Quintiles, Covance, PPD, CRL and ICON have set foot in Chinaby building new establishments and M&As. In China, homegrown leaders cover WuXi AppTec Co., Ltd.,Shanghai-headquartered ShangPharma Corporation, and Hangzhou Tigermed Consulting, with the respectiverevenue in Jan.-Sep., 2012 hitting USD374 million, USD94.47 million and USD29.84 million, the combinedproportion of 14% in China CRO market. In an aim to realize resource sharing and improve overall competitiveness, some domestic pharmaceuticalCRO enterprises seek joint development by setting up alliance. A case in point is ABO, which was establishedin 2005 merging nine research institutes including Academy of Military Medical Sciences, National Institutesfor Food and Drug Control, and National Center of Biomedical Analysis, gathering three national engineeringcenters and seven national engineering technology centers, with sharable hi-tech resources valuing RMB1billion. In 2012, ABO had 38 corporate members (including Sino Biological Inc. and Pharmaron), with thetotal area newly increasing by 40,000 sq meters to 270,000 sq meters or more and the total revenue growingby 28.6% year-on-year to over RMB1.8 billion which accounted for 6.4% in Beijing biomedical R&D serviceindustry. And the revenue generated by international orders rose by 14.7% YoY to RMB780 million. In Jan. 2013, JOINN Laboratories (Beijing), a member of ABO, took over the San Francisco-based R&D andproduction bases of Bayer, opening a new chapter for Chinese biomedical enterprises’ acquisition ofworldwide R&D bases transnational businesses in overseas countries. And JOINN Laboratories is scheduledto lavish USD100 million to set up a 300-mu(1mu=666.7sq meters)US-based Join Innovation Park, inan attempt to provide business incubator, technical support, international cooperation and other services forsmall-and medium-sized biomedical innovative enterprises in Silicon Valley and China. The report highlights the followings: international market, domestic macro- environment and polices, lawsand regulations of China CRO industry; status quo, market scale, competition pattern and developmentprediction of China CRO industry; Operation, CRO business and development dynamics in China of sixforeign and five domestic industrial players.table Of Content1. overview of cro industry1.1 definition & classification1.2 industry backgroundChina Contract Research Organization (CRO) Industry Report, 2012-2013
  • 2. 2. development environment of cro industry in china2.1 international environment2.2 industry environment2.3 policy environment3. market analysis of cro industry in china3.1 status quo3.2 market size3.3 competition pattern3.4 regional market3.4.1 beijing3.4.2shanghai3.4.3 chengdu3.5 prospects4.key cro enterprises worldwide4.1 covance inc.4.1.1 profile4.1.2 operation4.1.3 revenue structure4.1.4 business in china4.2 parexel international4.2.1 profile4.2.2 operation4.2.3 revenue structure4.2.4 business in china4.3 ppd4.3.1 profile4.3.2 operation4.3.3 business in china4.4 quintiles transnational corp.4.4.1 profile4.4.2 business in china4.5 charles river laboratories international, inc.4.5.1 profile4.5.2 operation4.5.3 revenue structure4.5.4 business in china4.6 asymchem inc.4.6.1 profile4.6.2 business in china5.key cro enterprises in chinaChina Contract Research Organization (CRO) Industry Report, 2012-2013
  • 3. 5.1 wuxi apptec co., ltd.5.1.1 profile5.1.2 operation5.1.3 revenue structure5.1.4 development trend and prospects5.2 shangpharma corporation5.2.1 profile5.2.2 operation5.2.3 revenue structure5.2.4 development trend and prospects5.3 venturepharm laboratories ltd.5.3.1 profile5.3.2 operation5.3.3 revenue structure5.3.4 development trend and prospects5.4 tigermed consulting co., ltd5.4.1 profile5.4.2 operation5.4.3 revenue structure5.4.4 gross margin5.4.5 clients and suppliers5.4.6 development trend and prospects5.5 sundia meditech co., ltd.About Us:Transparency Market Research is a market intelligence company providing global business informationreports and services. Our exclusive blend of quantitative forecasting and trends analysis providesforward-looking insight for thousands of decision makers. We are privileged with highly experienced team ofAnalysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques togather, and analyze information. Our business offerings represent the latest and the most reliable informationindispensable for businesses to sustain a competitive edge.Contact:ResearchMoz90 State Street,Suite 700,Albany NY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-997-4948Email: sales@researchmoz.usBlog: http://researchmoz.blogspot.com/Website: http://www.researchmoz.us/China Contract Research Organization (CRO) Industry Report, 2012-2013
  • 4. China Contract Research Organization (CRO) Industry Report, 2012-2013